Cargando…
Research progress on non-protein-targeted drugs for cancer therapy
Non-protein target drugs, especially RNA-based gene therapies for treating hereditary diseases, have been recognized worldwide. As cancer is an insurmountable challenge, no miracle drug is currently available. With the advancements in the field of biopharmaceuticals, research on cancer therapy has g...
Autores principales: | Zhang, Yiwen, Lu, Lu, Song, Feifeng, Zou, Xiaozhou, Liu, Yujia, Zheng, Xiaowei, Qian, Jinjun, Gu, Chunyan, Huang, Ping, Yang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011800/ https://www.ncbi.nlm.nih.gov/pubmed/36918935 http://dx.doi.org/10.1186/s13046-023-02635-y |
Ejemplares similares
-
Stemness-associated senescence genes as potential novel risk factors for papillary renal cell carcinoma
por: Zhang, Yiwen, et al.
Publicado: (2021) -
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment
por: Pan, Zongfu, et al.
Publicado: (2022) -
Single-cell sequencing analysis fibrosis provides insights into the pathobiological cell types and cytokines of radiation-induced pulmonary fibrosis
por: Sun, Zhiyong, et al.
Publicado: (2023) -
Research Progress on PARP14 as a Drug Target
por: Qin, Wei, et al.
Publicado: (2019) -
Progress of potential drugs targeted in lipid metabolism research
por: Liang, Kai, et al.
Publicado: (2022)